Skip to main content

Table 4 Outcomes and clinical variables between the groups.

From: Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?

ItemAll (N = 292)PLR ≤ 0.55 (n = 89)PLR > 0.55 (n = 203)P value+NLR ≤ 3.92 (n = 226)NLR > 3.92 (n = 66)P value+
LOS in the hospital (days, mean ± SD)16.0 ± 11.918.3 ± 12.915.0 ± 11.40.018*15.5 ± 12.017.8 ± 11.70.027*
LOS in the ICU (days, mean ± SD)6.3 ± 9.58.6 ± 10.95.4 ± 8.70.002*5.9 ± 9.67.7 ± 9.10.062
Anastomotic leaks [n(%)]36 (12.3)18 (20.2)18 (8.9)0.006*24 (10.6)12 (18.2)0.101
Complications   0.008*  0.671
 None [n(%)]266 (91.1)75 (84.3)191 (94.1) 207 (91.6)59 (89.4) 
 Cardiac [n(%)]10 (3.4)6 (6.7)4 (2.0)5 (2.2)5 (7.6) 
 Respiratory [n(%)]9 (3.1)6 (6.7)3 (1.5)7 (3.1)2 (3.0) 
 Infectious [n(%)]2 (0.7)02 (1.0)2 (0.9)0 
 Renal [n(%)]5 (1.7)2 (2.2)3 (1.5)5 (2.2)0 
Clavien-Dindo grade ≥ 3[n(%)]40(13.7)19 (21.3)21 (10.3)0.012*25 (11.1)15 (22.7)0.015*
In-hospital mortality [n(%)]9 (3.1)5 (5.6)4 (2.0)0.0982 (0.9)7 (10.6)< 0.001*
  1. P value+ were calculated for the comparison of groups based on the NLR and PLR values by statistical analysis; +Determined by the Mann-Whitney U test or Spearman’s rho test; *. P value < 0.05; ICU intensive care unit, LOS length of stay, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio